J.L. Pagani

Discipline

Psychologie (2)

Type de document

Articles (15) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Patients (14) Patients (14) Human beings (12) Use (10) Treatment (9) temps (durée) (7) Time (7) infection (6) Infection (6) Days (6) Older people (6) thérapie (5) Control (5) Therapeutics (5) Critically ill (5) Critical care medicine (5) Blood (5) hôpital (4) analyse (4) effet (4) adulte (4) Admission (4) Ci (Chinese poetry) (4) Management (4) Analysis (4) Infections (4) adulte (4) risque (3) pharmacocinétique (3) mortalité (3)

Documents écrit par J.L. Pagani (15) | parle de J.L. Pagani (0)

The effect of duration of antimicrobial treatment for bacteremia in critically ill patients on in-hospital mortality - Retrospective double center analysis.
P. Zuercher et al.
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
A. Kritikos et al. (18 mai 2022)
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital.
J. Battistolo et al.
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study.
J. Pugin et al. (20 avr. 2021)
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
J. Lourenco et al. (2021)
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients.
F. Lamoth et al.
Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
L.A. Decosterd et al. (10 nov. 2020)
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital.
E. Kampouri et al. (2020)
Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years.
P. Eggimann et al.
Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.
Y.A. Que et al. (2014)
Thymoma, immunodeficiency, and herpes simplex virus infections.
M. Méan et al. (2009)
Management of catheter-related infection.
J.L. Pagani et al.
Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.
J.L. Pagani et al.
Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients.
C. Csajka et al.
Monitoring responses to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration
P. Burgisser et al.